microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate

microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate

BackgroundMicroRNAs are small non-coding RNA that regulate gene expression at a post-transcriptional level affecting several cellular processes including inflammation, neurodegeneration and remyelination. Different patterns of miRNAs expression have been demonstrated in multiple sclerosis compared t...

Full description

Bibliographic Details
Main Authors: María I. Dominguez-Mozo, Ignacio Casanova, Laura De Torres, Yolanda Aladro-Benito, Silvia Perez-Perez, Angel Garcia-Martínez, Patricia Gomez, Sara Abellan, Esther De Antonio, Carlos Lopez-De-Silanes, Roberto Alvarez-Lafuente
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
multiple sclerosis
microRNA
biomarker
cognitive dysfuction
brain atrophy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.904683/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.904683/full

Similar Items